News from invitae corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 11, 2019, 07:30 ET Invitae to Acquire Clear Genetics

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Clear...


Nov 06, 2019, 16:05 ET Invitae Reports $56.5 Million in Quarterly Revenue Driven by 129,000 Samples

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the third quarter ended...


Nov 05, 2019, 08:19 ET Invitae Highlights Importance of Medical Genetics, Honors Excellence in Genetic Counseling at National Society of Genetic Counselors (NSGC) 38th Annual Conference

Researchers from Invitae Corporation (NYSE: NVTA), a leading medical genetics company, are presenting research this week at the National Society of...


Oct 23, 2019, 07:30 ET Invitae to announce third quarter 2019 financial results on November 6, 2019

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its third quarter 2019 financial results on ...


Oct 17, 2019, 07:30 ET Research presented by Invitae at the American Society of Human Genetics Meeting Pushes Science and Practice of Genetics Forward

Researchers from Invitae Corporation (NYSE: NVTA), a leading medical genetics company, are presenting data showing the increasing utility of genetic...


Sep 09, 2019, 07:30 ET Invitae Expands Detect Program to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of Detect Hereditary Pancreatic Cancer, a testing program...


Sep 06, 2019, 07:00 ET Invitae Prices Upsized Offering of $300 Million of Convertible Senior Notes

Invitae Corporation (NYSE: NVTA) announced the pricing on September 5, 2019 of $300.0 million aggregate principal amount of 2.00% convertible senior...


Sep 04, 2019, 16:05 ET Invitae Announces Proposed Offering of $200 Million of Convertible Senior Notes

Invitae Corporation (NYSE: NVTA) today announced its intention to offer, subject to market conditions and other factors, $200.0 million aggregate...


Aug 06, 2019, 16:15 ET Invitae Reports $53.5 Million in Quarterly Revenue Driven by More Than 111,000 Samples in Quarterly Volume

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the second quarter ended...


Jul 24, 2019, 07:30 ET Invitae Launches Detect Programs to Make it Easier for Patients to Get Genetic Testing for Prostate Cancer, Muscular Dystrophy and Heart Conditions

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the availability of its Detect programs to provide no-charge genetic...


Jul 23, 2019, 07:30 ET Invitae to announce second quarter 2019 financial results on August 6, 2019

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its second quarter 2019 financial results...


Jul 11, 2019, 16:06 ET Invitae to Acquire Jungla to Advance Genetic Variant Interpretation, Adds Supplemental RNA Analysis to Deliver Deeper, More Informative Results to Patients

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Jungla...


Jun 20, 2019, 21:00 ET Invitae Reports Inducement Grants Under NYSE Rule 303A.08 to Former Employees of Singular Bio, Inc. in Connection with Closing of Acquisition

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it granted time-based and development milestone-based...


Jun 17, 2019, 07:30 ET Invitae to Acquire Singular Bio to Help Increase Access to Genetic Screening in Early Pregnancy

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Singular...


Jun 12, 2019, 07:30 ET Invitae Announces ID YOUR IRD Program to Expand Access to Genetic Testing for Inherited Retinal Disorders

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of ID YOUR IRD, an initiative with Spark Therapeutics to offer...


Jun 03, 2019, 07:30 ET Invitae introduces new service to make it easier for consumers to receive the medical genetic testing that experts trust

Invitae (NYSE: NVTA), a leader in medical genetics, today announced the availability of its new service for consumers, which makes it easier for...


May 31, 2019, 07:30 ET Research from Invitae Demonstrates the Importance of Germline Multigene Panel Testing in Guiding Therapy for Expanding Groups of Cancer Patients

Researchers from Invitae (NYSE: NVTA), a leading medical genetics company, will present data that underscore the clinical utility of comprehensive...


May 22, 2019, 07:30 ET Invitae to Present at the 2019 William Blair Growth Stock Conference

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of...


May 15, 2019, 07:41 ET Invitae to Present at the UBS Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), the leader in advanced medical genetics, today announced that Sean George, co-founder and chief executive officer...


May 07, 2019, 16:05 ET Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year

Invitae Corporation (NYSE: NVTA), the leader in advanced medical genetics, today announced financial and operating results for the first quarter...


May 03, 2019, 07:30 ET New Study From Invitae Highlights the Importance of Multigene Genetic Testing for Uterine Cancer Patients

Researchers from Invitae (NYSE: NVTA), a leading genetics company, will present a study of more than 6,500 patients with uterine cancer showing that...


Apr 23, 2019, 07:30 ET Invitae to announce first quarter 2019 financial results on May 7, 2019

Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that it will report its first quarter 2019 financial results on...


Apr 02, 2019, 07:30 ET Research Underscores Need for Updated Guidelines to Include Multigene Testing for Cancer Patients

Researchers from Invitae (NYSE: NVTA), a leading genetics company, will present data from more than 113,000 patients that support updating genetic...


Mar 14, 2019, 07:30 ET Invitae to Present at the Oppenheimer 29th Annual Healthcare Conference

Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae,...


Mar 06, 2019, 21:31 ET Invitae Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock

Invitae Corporation (NYSE: NVTA) today announced the exercise in full of the underwriters' option to purchase an additional 1,350,000 shares of its...